info icon

This is a non-core endpoint: only basic statistics are computed.

See these related core endpoints for full statistics:

Carcinoma in situ of skin of eyelid, including canthus

CD2_INSITU_SKIN_EYELID_EXALLC

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

None

-

2. Check conditions

None

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 D04.1&
  • Hospital discharge: ICD-9 2321
  • Cause of death: ICD-10 D04.1&
  • Cause of death: ICD-9 2321

2 out of 7 registries used, show all original rules.

-

4. Check minimum number of events

None

-

5. Include endpoints

None

-

6. Filter based on genotype QC (FinnGen only)

None

-

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D04
Name in latin
Carcinoma in situ cutis palpebrae

Case counts by codes

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 65 28 37
Unadjusted period prevalence (%) 0.01 0.01 0.02
Median age at first event (years) 75.37 75.82 75.03

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
58
Matched controls
581
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D04.1
ICD-10 Finland
Carcinoma in situ: Skin of eyelid, including canthus
+∞
80.4
57
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
+∞
16.4
15
*
L57.0
ICD-10 Finland
Actinic keratosis
15.3
15.3
27
31
TQW99
NOMESCO Finland
Other minor procedure on skin
31.7
13.9
18
8
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
25.3
13.1
18
10
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
13.0
12
*
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
39.5
12.4
15
5
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
+∞
11.9
11
*
CBB50
NOMESCO Finland
Excision of lesion of eyelid and reconstruction using graft or flap
+∞
11.9
11
*
CBA10
NOMESCO Finland
Biopsy of eyelid
54.6
11.5
13
*
CBB30
NOMESCO Finland
Excision of lesion of eyelid
74.1
11.1
12
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
+∞
10.7
10
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
10.7
10
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
12.9
10.6
19
21
ZXC15
NOMESCO Finland
Use of photodynamic technique
+∞
9.6
9
*
D23.1
ICD-10 Finland
Benign neoplasm: Skin of eyelid, including canthus
26.6
8.4
11
5
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
+∞
7.4
7
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
+∞
7.4
7
*
L04AA06
ATC
mycophenolic acid; systemic
+∞
7.4
7
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
30.3
6.4
8
*
127
Kela drug reimbursment
Transplant complication
+∞
6.4
6
*
Z94.0
ICD-10 Finland
Kidney transplant status
+∞
6.4
6
*
C44.12
ICD-10 Finland
Spinocellular carcinoma of the skin of the eyelids including the corner of the eye
+∞
6.4
6
*
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
+∞
6.4
6
*
ZXC50
NOMESCO Finland
Cryotherapy
14.7
6.4
10
8

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
46
114
11.38
21.36
4.1
1.5
—
—
—
0
0
22
30
10.57
16.36
1.9
1.2
—
—
—
0
0
14
12
14.59
14.00
1.1
1.0
—
—
—
0
0
10
15
7.70
6.51
1.0
1.3
—
—
—
0
0
34
152
3.59
6.06
10.3
4.8
—
—
—
0
0
33
146
3.56
5.96
5.9
4.1
—
—
—
0
0
42
231
3.31
5.10
10.5
4.5
2.2
1.7
e9/l
0.32
37
211
41
226
3.21
4.89
10.7
4.4
0.6
0.6
e9/l
0.05
36
202
41
229
3.14
4.73
10.7
4.4
0.0
0.0
e9/l
0.06
36
206
41
236
3.00
4.37
11.0
4.4
0.2
0.2
e9/l
0.15
35
213
14
44
3.78
4.05
2.9
4.3
1.5
1.5
mmol/l
0.01
14
39
13
39
3.92
4.01
5.3
7.7
—
—
—
0
0
10
25
4.55
3.86
3.0
6.1
23.9
24.9
mmol/l
—
10
19
38
220
2.75
3.85
2.5
2.1
89.1
90.8
pmol/l
0.09
24
100
39
231
2.72
3.74
8.9
5.0
1.2
1.2
mmol/l
0.09
33
201
30
158
2.67
3.61
2.7
2.1
2.4
2.3
mmol/l
0.38
25
126
48
323
2.86
3.47
6.8
5.2
—
326.4
—
0
12
13
45
3.36
3.24
5.4
4.1
—
—
—
0
0
57
448
3.21
3.02
31.4
15.9
35.6
23.8
mg/l
1.08
50
360
50
358
2.72
2.96
5.3
4.5
20.2
14.4
mm/h
0.98
44
322
26
139
2.45
2.93
3.2
2.2
—
—
—
0
0
16
70
2.71
2.67
11.7
5.5
1.1
1.0
mmol/l
0.48
16
60
24
129
2.36
2.63
6.4
3.0
—
—
—
0
0
58
473
3.10
2.56
33.3
18.5
101.7
87.3
umol/l
0.69
58
473
9
27
3.70
2.50
1.3
2.0
1.3
1.6
g/l
—
9
21
7
17
4.48
2.43
3.6
2.1
—
—
—
0
0
31
193
2.16
2.35
14.3
8.4
0.0
0.0
e9/l
0.00
25
160
9
30
3.31
2.25
3.1
4.8
24.6
25.2
mmol/l
—
9
30
58
481
2.91
2.22
32.9
19.2
138.9
139.6
mmol/l
1.06
58
465
58
483
2.86
2.22
33.8
19.2
4.0
4.0
mmol/l
0.39
58
465
24
138
2.17
2.19
6.5
3.1
0.1
0.5
e6/l
1.25
19
102
28
175
2.05
2.04
3.8
3.4
—
—
—
0
0
5
11
4.82
1.98
1.2
1.1
—
—
—
0
0
22
128
2.09
1.92
3.2
2.5
394.7
3318.3
umol/l
0.49
16
103
54
436
2.41
1.92
5.6
7.8
39.5
41.9
mmol/mol
0.97
48
397
28
179
1.99
1.89
7.1
4.0
46.3
83.3
e6/l
0.44
20
133
8
29
3.00
1.86
3.4
6.5
93.7
91.8
%
—
8
29
8
32
2.71
1.66
2.9
5.9
0.3
0.7
%
—
8
32
7
26
2.89
1.63
6.3
4.2
—
—
—
0
0
8
33
2.62
1.60
3.4
5.8
1.4
1.7
%
—
8
33
18
104
2.01
1.57
3.3
3.6
—
—
—
0
0
12
59
2.27
1.55
3.1
5.3
11.8
10.7
kpa
0.46
12
54
12
59
2.27
1.55
3.1
5.3
5.0
5.1
kpa
0.10
12
54
25
163
1.87
1.54
4.9
4.4
—
—
—
0
0
11
53
2.29
1.48
1.5
1.5
—
—
—
0
0
51
419
2.01
1.48
4.7
4.5
1.1
1.2
mmol/l
0.56
45
363
43
335
1.84
1.47
8.3
4.5
—
—
—
0
0
53
442
2.08
1.46
5.2
5.0
4.1
4.3
mmol/l
1.00
47
393
54
455
2.10
1.42
5.8
5.6
2.3
2.5
mmol/l
0.86
48
396
47
379
1.87
1.41
29.2
16.5
38.0
38.9
%
0.21
28
226
24
162
1.76
1.30
6.6
3.3
8.8
419.9
e6/l
0.52
17
124
18
111
1.86
1.29
8.4
4.5
—
—
—
0
0
13
72
2.01
1.26
2.1
1.6
—
—
—
0
0
5
20
2.62
1.17
1.4
1.2
—
—
—
0
0
8
41
2.08
1.13
1.1
1.2
—
—
—
0
0
13
76
1.89
1.08
4.7
2.7
19.8
21.5
%
0.25
13
68
23
161
1.66
1.07
2.4
2.1
55.3
58.5
u/l
0.15
18
147
51
437
1.78
1.06
5.3
5.0
1.4
1.4
mmol/l
0.39
45
382
49
420
1.68
0.97
4.6
4.7
2.0
2.0
mu/l
0.09
44
360
27
202
1.58
0.95
11.8
12.8
1.3
1.5
inr
—
5
65
25
184
1.58
0.94
3.3
3.9
—
—
—
0
0
11
64
1.87
0.93
2.7
2.4
334.5
210.9
ng/l
0.35
11
57
13
81
1.76
0.89
4.5
2.6
2.2
2.1
g/l
0.37
13
70
13
83
1.71
0.82
7.7
4.1
—
—
—
0
0
5
24
2.17
0.76
4.0
1.6
—
—
—
0
0
7
39
1.89
0.75
6.0
4.7
21.9
24.4
mmol/l
—
7
32
5
25
2.08
0.74
2.4
1.4
—
—
—
0
0
23
174
1.50
0.74
3.2
2.8
32.3
89.0
mg/l
1.15
18
105
7
43
1.70
0.69
1.1
1.3
—
—
—
0
0
5
28
1.85
0.67
1.4
1.1
—
—
—
0
0
11
71
1.66
0.67
1.1
1.3
—
—
—
0
0
10
63
1.69
0.66
3.2
1.6
—
—
—
0
0
52
470
1.53
0.63
27.8
14.9
—
—
—
0
0
5
30
1.72
0.62
1.6
1.3
—
—
—
0
0
24
189
1.43
0.62
3.5
3.7
5.8
9.5
mg/mmol
0.47
19
113
6
35
1.79
0.59
2.8
2.3
—
—
—
0
0
9
59
1.61
0.58
4.9
4.1
-0.5
1.6
mmol/l
—
9
45
6
37
1.68
0.57
2.8
2.6
—
—
—
0
0
9
63
1.50
0.55
4.9
4.0
—
—
—
0
0
6
40
1.55
0.53
2.5
2.9
—
—
—
0
0
0
17
0.00
0.41
0.0
4.2
—
—
—
0
0
10
73
1.44
0.37
2.2
2.6
1.6
1.5
%
—
10
64
49
454
1.32
0.37
5.9
5.2
6.0
6.2
mmol/l
0.20
43
394
27
233
1.27
0.36
6.1
4.8
32.3
37.1
ng/l
0.28
21
186
10
131
0.72
0.35
3.4
4.3
—
—
—
0
0
5
39
1.31
0.23
1.6
1.3
—
—
—
0
0
11
89
1.28
0.22
2.6
1.6
29.6
30.4
s
0.27
11
82
5
41
1.24
0.22
2.6
1.8
—
—
—
0
0
11
91
1.25
0.19
1.2
1.2
—
—
—
0
0
12
134
0.87
0.10
5.3
4.1
—
—
—
0
0
8
75
1.08
0.08
1.0
1.3
—
37.3
iu/ml
—
0
27
35
337
1.08
0.07
5.3
4.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
0
6
0.00
0.00
0.0
5.0
—
7.6
—
0
6
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
12.2
—
—
—
0
0
0
5
0.00
0.00
0.0
2.4
—
6.9
—
0
5
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
2.6
—
13.1
—
0
5
0
5
0.00
0.00
0.0
1.4
—
24.3
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

Index endpoint: CD2_INSITU_SKIN_EYELID_EXALLC – Carcinoma in situ of skin of eyelid, including canthus

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).